32.7 %In 2019, 32.7% of all adolescent deaths were due to transport injuries, unintentional injuries, or interpersonal violence and conflict.
Camerountransport injuries, unintentional injuries, or interpersonal violence and conflictobserved 2019published 2021Lancet (London, England)europe_pmcdocument of 13 observations
2.2 %Le paludisme cause 2,2 % de mortalité dans la population générale.
Camerounpaludismeobserved 2004HAL · Unilimdocument of 98 observations
40 %In 2010, high blood pressure was the leading risk factor for deaths due to cardiovascular diseases, chronic kidney disease, and diabetes in every region, causing more than 40% of worldwide deaths from these diseases.
Cameroundiabète (non précisé) · hypertension artérielle · maladie rénale chronique · maladies cardiovasculairesobserved 2010published 2014The lancet. Diabetes & endocrinologyeurope_pmcdocument of 28 observationsDOI 10.1016/s2213-8587(14)70102-0
1.6 %In Cameroon, the prevalence of SIVgor was estimated to be 1.6% (range, 0% to 4.6%).
CamerounSIVgorpublished 2009Journal of VirologyOpenAlexdocument of 4 observationsDOI 10.1128/jvi.02129-09
8,396 adultsDuring the Family Health Days campaign from 17th October to 25th November 2011, 8,396 adults were tested for HIV.
CamerounVIH/sidaobserved 17th October to 25th November 2011published 2012Journal of the International AIDS Societyeurope_pmcdocument of 39 observations
1.4 %The prevalence of suspected cases of epilepsy was 1.4% among the registered population in the surveyed communities.
CamerounépilepsieHAL · Unilimdocument of 53 observations
4 yearsThe median duration of diabetes diagnosis among patients in the study was four years.
Cameroundiabète de type 2published 2012Cardiovascular journal of Africaeurope_pmcdocument of 11 observations
1,300,000 deathsIn 2017, tracheal, bronchus, and lung cancer caused 1.3 million deaths in men.
Camerountracheal, bronchus, and lung cancerobserved 2017published 2019JAMA oncologyeurope_pmcdocument of 25 observationsDOI 10.1001/jamaoncol.2019.2996
5.8 %Meningitis was the underlying cause of 5.8% of diabetic comas admitted to the endocrinology service of Yaounde Central Hospital between November 1999 and October 2002.
Camerouncoma · méningite (non précisée)observed November 1999 to October 2002published 2008Annals of tropical medicine and parasitologyeurope_pmcdocument of 12 observationsDOI 10.1179/136485908x252188
3.3 %Hypertension prevalence among Pygmies in Cameroon was 3.3% [95% CI 0.4–6.2].
Camerounhypertension artériellepublished 2019Journal of hypertensioneurope_pmcdocument of 20 observationsDOI 10.1097/hjh.0000000000002165
3.92 odds_ratioThe T allele was significantly associated with a greater risk of developing type 2 diabetes mellitus as compared to the G allele (OR = 3.92, 95% CI 2.04–7.67, p < 0.001).
Cameroundiabète de type 2published 2015Clinical and translational medicineeurope_pmcdocument of 2 observations
23 %23% of the pre-intervention group had newly diagnosed diabetes.
Cameroundiabète (non précisé)published 2009Diabetes & metabolismeurope_pmcdocument of 9 observations
Anopheles gambiae (s.l.) mosquitoes from South-West Cameroon were found resistant to pyrethroids (deltamethrin and permethrin) in all locations.
Camerounpaludismepublished 2018Parasites & vectorsPubMeddocument of 5 observations
6 patientsA repeat CT showed evidence of tumour shrinkage especially of the suprasellar extension in all six patients after treatment with bromocriptine.
Camerounprolactinomapublished 1993British journal of neurosurgeryeurope_pmcdocument of 2 observations
13.2 %The prevalence of overweight/obesity was 13.2% in girls in nursery and primary school children in urban Cameroon.
Camerounoverweight/obesitypublished 2017BMC obesityeurope_pmcdocument of 5 observationsDOI 10.1186/s40608-017-0146-4
43.2 %In 2013, 43.2% of people with diabetes in the Africa Region (AFR) were aged 40–59 years.
Cameroundiabète (non précisé)observed 2013published 2014Diabetes research and clinical practiceeurope_pmcdocument of 14 observations
11 %Each kg/m² higher BMI was associated with 11% higher odds of hypertension.
Camerounhypertension artérielle · obésitépublished 2017BMC public healtheurope_pmcdocument of 9 observations
11 %The global seroprevalence was 11% (151/1376) in Cameroon.
Camerounarbovirusespublished 2022Vector borne and zoonotic diseases (Larchmont, N.Y.)europe_pmcdocument of 9 observations
3 yearsThe duration of diabetes was 3.0 years.
Cameroundiabète de type 2published 2019Diabetes research and clinical practiceeurope_pmcdocument of 4 observations
Knowledge score was significant in the intervention group at 2 months (p<0.01).
Cameroundiabète de type 1HAL · Unilimdocument of 50 observations
0.05 %Among 4,022 blood samples of bats collected from Africa during 2015–2017, 2–37 bats (0.05%–0.92%) were seropositive for Zaire Ebola virus.
CamerounZaire Ebola virusobserved 2015-2017published 2018Emerging infectious diseasesOpenAlexdocument of 3 observations
77.1 %Among 109 Cameroonian patients with sickle cell disease (SCD), 84/109 samples (77.1%) supposedly expressed a 'normal' D-positive phenotype.
CameroundrépanocytoseHAL · Unilimdocument of 45 observations
0.7 %The median estimated 5-year CVD risk using the Framingham equation was 0.7%.
Camerounmaladies cardiovasculairespublished 2017Tropical diseases, travel medicine and vaccineseurope_pmcdocument of 8 observations
15 %Total insulin requirements decreased by 15% (equivalent to −4 IU/day) posthemodialysis in type 2 diabetic patients with end-stage renal disease on maintenance hemodialysis.
Cameroundiabète de type 2 · end-stage renal diseasepublished 2010Diabetes careeurope_pmcdocument of 5 observationsDOI 10.2337/dc09-2176
38.5 %At endpoint, 38.5% of 141 HIV-infected adult patients were lost to follow-up.
CamerounVIH/sidaobserved 2009-2011published 2013PLoS ONEOpenAlexdocument of 8 observationsDOI 10.1371/journal.pone.0072680
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.